REG - Wilmington PLC - Director/PDMR Shareholding
RNS Number : 0886AWilmington PLC27 May 202127 May 2021
Wilmington plc
Director/PDMR Shareholding
In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, Wilmington plc (the 'Company') was advised on 27 May 2021 that:
· Helen Sachdev, non-executive director, bought 2,146 ordinary shares of 5p each in the Company on 27 May 2021 at an average of 196.96 pence per share. Her resultant holding of ordinary shares of 5p each is 10,000 which represent 0.011% of the issued share capital with voting rights.
For further information, please contact:
Wilmington plc 020 7490 0049
Guy Millward, Company Secretary and Chief Financial Officer
Notes to Editors
Wilmington is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Professional and Healthcare areas. Wilmington employs close to 1,000 people and has customers in 120 countries. Wilmington plc is a premium listed Company on the main market of the London Stock Exchange.
1.
Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")
a)
Name
HELEN SACHDEV
2.
Reason for the notification
a)
Position /status
NON-EXECUTIVE DIRECTOR
b)
Initial notification / amendment
INITIAL NOTIFICATION
3.
Details of the Issuer
a)
Name
WILMINGTON PLC
b)
LEI code
N/A
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
ORDINARY SHARES IN WILMINGTON PLC
ISIN: GB0009692319
b)
Nature of the transaction
PURCHASE OF ORDINARY SHARES
c)
Price(s) and volume(s)
Price(s)
Volume(s)
1.9696
2,146
d)
Aggregated information
Aggregated volume
Price
N/A
e)
Date of the transaction
27 MAY 2021
f)
Place of the transaction
LONDON
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHARMITMTTTBJB
Recent news on Wilmington
See all newsREG - Wilmington PLC - APM sold for EUR 26 million
AnnouncementREG - Wilmington PLC - SAYE and Director/PDMR Shareholding
AnnouncementREG - Wilmington PLC - Half-year Report
AnnouncementREG - Wilmington PLC - Board Changes
AnnouncementREG - Wilmington PLC - MiExact sold for £9.6 million
Announcement